drugset / Trial / NCT02918084
CONcurrent vs SEqueNTial Adjuvant Treatments in Early Breast Cancer
Phase 3
Active not recruiting
1000 enrolled
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy
Clinical Research Technology S.r.l. · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
Breast cancer is the most common form of cancer among women. For patients candidated for adjuvant chemotherapy and endocrine therapy the optimal timing for their has not been clearly defined yet.
Timeline
- Start
- 2013-06
- Primary completion
- 2028-06
- Completion
- 2028-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anastrozole | Other / unclassified | — | — |
| Subject | Exemestane | Small molecule | — | — |
| Subject | Letrozole | Other / unclassified | — | — |